Nicox

en fr

About Us
Pipeline, Markets and Science
Investors
News and Events
Contact Us

U.S. FDA Approval of VYZULTA (latanoprostene bunod ophthalmic solution), 0.024%

November 3, 2017

← Back to blog page

Nicox

Contact Us
Subscribe to news
Legal Notice

Search

© Copyright Nicox, all rights reserved

Cookies

By continuing to use this website, you agree to our Cookie Policy.